Elimination of Disparities in the Era of Precision Oncology

Elimination of Disparities in the Era of Precision Oncology

Focusing on Your Primary Care Contribution, The Jane Cooke Wright, MD, Oncology Symposium

Not a member of My prIME? Join now for instant access.

Meeting Overview

A prIME Oncology satellite symposium to be held in conjunction with The National Medical Association 116th Annual Convention & Scientific Assembly, focusing on the role of the primary care physician in the elimination of disparities in oncology.

Date and Location

Tuesday, August 14, 2018
7.00 AM 9.00 AM

Panzacola F3 & 4
Rosen Shingle Creek
9939 Universal Blvd
Orlando, Florida 32819



Tuesday, August 14, 2018



Orlando, Florida, United States



2.0 AMA PRA Category 1 Credits

7.00 AM Welcome, introduction, and precision oncology quiz
Edith P. Mitchell, MD, FACP, FCPP
7.05 AM Keynote presentation: Precision oncology; Today and tomorrow
Edith P. Mitchell, MD, FACP, FCPP
7.25 AM Audience questions
7.30 AM Breast cancer
Worta McCaskill-Stevens, MD, MS
7.50 AM Human papilloma virus-related cancers
Douglas R. Lowy, MD
8.10 AM Audience questions, breast cancer, and HPV-related cancers
8.15 AM Non-small cell lung cancer
Jhanelle Gray, MD
8.35 AM Colorectal cancer
Durado D. Brooks, MD, MPH
8.55 AM Audience questions/prIME Points™
Edith P. Mitchell, MD, FACP, FCPP
9.00 AM Adjourn


  • Edith P. Mitchell, MD, FACP, FCPPThomas Jefferson University
    Philadelphia, Pennsylvania, United States
  • Faculty

  • Durado D. Brooks, MD, MPH American Cancer Society
    Atlanta, Georgia, United States
  • Jhanelle E. Gray, MDH. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida, United States
  • Douglas R. Lowy, MDNational Cancer Institute
    Bethesda, Maryland, United States
  • Worta J. McCaskill-Stevens, MD, MSNational Cancer Institute
    Rockville, Maryland, United States

This educational activity is specifically designed to meet the needs of internists, general practitioners, surgeons, obstetricians/gynecologists, pulmonologists, and other healthcare providers involved in the diagnosis, treatment, and/or follow-up of patients with cancer.

After successful completion of this educational activity, participants should be able to:

  • Employ current evidence-based best practices for using screening and diagnostic tools for various malignancies in order to decrease the incidence of disparities
  • Assess the implications of disparities in the management of breast cancer, non-small cell lung cancer, colorectal cancer, and HPV-related cancers, and implement strategies to improve outcomes

This educational activity is supported by grants from Bristol-Myers Squibb and Merck and Co, Inc.

Continuing Education

prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

prIME Oncology designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity is provided by prIME Oncology.

Sunshine Act/EFPIA

prIME Oncology complies with all Sunshine Act reporting requirements as outlined by CMS and applicable manufacturers and with EFPIA Disclosure Code reporting requirements.


Disclosure of Relevant Financial Relationships

prIME Oncology assesses the relevant financial relationships of its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure Regarding Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.